RxDoctor Payments Data

Jade Fettig, MD

Dermatology · Greenwood Village, CONPI 1699153478

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.8% of the total across 328 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 29 manufacturers reported payments, led by AbbVie at 25.0% of the total. 2025 is the largest year on record at $1,925, 2.5 times the $755 reported in 2019.

$7,875in general payments, 2019–2025

Across 328 payments — averaging $24.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Sanofi$831
  • Regeneron Healthcare Solutions, Inc.$611
  • Galderma Laboratories, L.p.$537
  • Johnson & Johnson$524
  • LEO Pharma Inc.$512
  • plus $3K from 23 others

What the payments were for

  • Food & beverage$7,62397%
  • Education$2523%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,875 in reported general payments places this provider in the 80th percentile of 280 dermatology providers in Colorado.

See all dermatology providers in Colorado

Medicare billing

Part B allowed, 2024
$112,185
Medicare patients
418
Services billed
13,574

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab13$45,892
Fluorouracil21$1,684
Clobetasol Propionate25$1,250
Triamcinolone Acetonide44$491
ValacyclovirValacyclovir Hcl24$418
Minoxidil34$268
Doxycycline Hyclate19$228
Mupirocin20$136

Paid to pharmacies, not to this prescriber.

Other dermatology in Greenwood Village

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →